|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
27 February 2023 |
|
Main ID: |
NCT05619848 |
|
Date of registration:
|
09/11/2022 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery
RUILS |
|
Scientific title:
|
Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery |
|
Date of first enrolment:
|
October 25, 2022 |
|
Target sample size:
|
87 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT05619848 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Double (Participant, Care Provider).
|
|
Phase:
|
Early Phase 1
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Guo Zheng, Ph. D |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Second of Shanxi Medical University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Age: 18-65; ASA grade I-II; no significant cardiopulmonary disease; no history of surgery
in the corresponding surgical area; no coagulopathy.
Exclusion Criteria:
refusal to participate by the present experimenter; those with severe
cardio-cerebrovascular disease, severe hepatic and renal dysfunction; taking medications
affecting the neuromuscular junction; area of monitoring site for skin breakers; patients
with intraoperative bleeding, anaphylactic shock, or other serious complications; patients
requiring intraoperative neurophysiological monitoring (including sensory, motor evoked
potentials).
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Spinal Stenosis Lumbar
|
|
Intervention(s)
|
|
Drug: Rocuronium Bromide
|
|
Primary Outcome(s)
|
|
use of rocuronium bromide
[Time Frame: Perioperative period]
|
|
Secondary Outcome(s)
|
|
The general condition of the paraspinal muscle
[Time Frame: Perioperative period]
|
|
Secondary ID(s)
|
|
yuewei20221109
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|